Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine prophylaxis dose finding for post-spinal hypotension
NCT03234816Phase 4Completed
- Sponsor
- Cairo University
- Start
- Aug 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of norepinephrine in hypotension (3 arms), sponsored by Cairo University. Primary endpoint: Incidence of postspinal hypotension. Started Aug 2017; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT03234816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234816.